Even though the industry raised $258 million last week, there's no shortage of financings in the pipeline. Bankers were tripping over themselves to get to the SEC, filing $308.2 million in biotech financings. The proposed deals include three IPOs (Gene Logic, Cell Pathways and Dura's Spiros Development Corp II, see below). Last week's quarter-billion dollar performance ranks fifth in weekly takes for the industry this year.

The sector's strength was highlighted by the speed at which deals were closing.